CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-15 | Mostafa Adam S. Chief Financial Officer | Sale | −5,417 | $7.84 | $42K | 123,585 |
| 2021-06-15 | Ragan Paula President and CEO | Grant or award | +44,826 | 451,074 | ||
| 2021-06-02 | Bridger Gary Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | Aliski William Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | WYZGA MICHAEL S Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | Stewart Murray Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | Lawton Alison Frances Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | MCGIRR DAVID W J Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | Russo Rene Director | Grant or award · Stock Option (right to buy) | +6,000 | $9.50 | $57K | 6,000 |
| 2021-06-02 | Ragan Paula President and CEO | Sale | −2,400 | $9.50 | $23K | 406,248 |
| 2021-06-01 | Ragan Paula President and CEO | Sale | −4,104 | $9.41 | $39K | 408,648 |
| 2021-05-03 | Ragan Paula President and CEO | Sale | −2,400 | $8.33 | $20K | 412,752 |
| 2021-04-05 | Ragan Paula President and CEO | Sale | −2,400 | $9.17 | $22K | 415,152 |
| 2021-03-24 | Mostafa Adam S. Chief Financial Officer | Grant or award | +83,163 | 112,752 | ||
| 2021-03-24 | Taveras Arthur Chief Scientific Officer | Grant or award | +8,035 | 8,035 | ||
| 2021-03-24 | Cadavid Diego Chief Medical Officer | Grant or award | +8,035 | 8,035 | ||
| 2021-03-24 | Ragan Paula President and CEO | Grant or award | +144,629 | 417,552 | ||
| 2021-03-24 | Meisner Derek M General Counsel | Grant or award | +47,728 | 64,394 | ||
| 2021-03-02 | Ragan Paula President and CEO | Sale | −2,400 | $9.74 | $23K | 272,923 |
| 2021-02-02 | Ragan Paula President and CEO | Sale | −2,400 | $7.88 | $19K | 275,323 |
Page 10 of 25 · 490 trades